Country Study Operations Manager (Temporary - 12 Months) - UK - FSP

Erek Daily Alerts - PAREXEL, Uxbridge, Greater London

Country Study Operations Manager (Temporary - 12 Months) - UK - FSP

Salary not available. View on company website.

Erek Daily Alerts - PAREXEL, Uxbridge, Greater London

  • Full time
  • Temporary
  • Remote working

Posted 2 weeks ago, 7 Dec | Get your application in now before you miss out!

Closing date: Closing date not specified

job Ref: 0b462521cd404bdba69966456de470a4

Full Job Description

In this role, the Country Study Operations Manager will be responsible for study and country level activities from start up through conduct and study close. The Country Study Operations Manager has responsibility for study management aspects of assigned studies, including vendor and budget management., Regional / Country / Study level implementation of Start-up and Site Activation Plans

Responsible for country / study level Recruitment Strategy

Responsible to support the development of study level plans

Communication with the local team and internal stakeholders and CRO partner as applicable and as listed above to ensure efficient and timely study delivery of the agreed plans

Responsible for study and / or country vendor management and oversight including follow up and coordination of vendor deliverables

The Country Study Operational Manager I will be able to work independently and exercise their own judgement.

For every role, we look for professionals who have the determination and courage always to put patient well-being first. That to us is working with heart.

Here are a few requirements specific to this advertised role.

Minimum of 5 years of relevant clinical trial management experience.

Excellent leadership, communication, and organizational skills. Able to multi-task under limited direction and on own initiative.

M.S / M.A / Ph.D or B.A / B.S / nursing degree is essential.

Prior and demonstrable experience working at a senior level within Study start up preferred.

Parexel supports clinical studies across the full range of therapeutic areas, and we have longstanding partnerships with a vast client base.

We supported the trials of most of today's top 50 best-selling drugs, but equally we enable more niche drug developments that are critical to the well-being of many patients.